Respiratory Drugs and Devices Market: Industry Growth, Size, Share and Forecast 2018-2023

1. Orion Market Research Respiratory Drugs and Devices Market: Global Size, Industry Trends, Leading Players, Share and Forecast 2018- 2023 Request a free sample of our report on Respiratory Drugs and Devices Market: https://www.omrglobal.com/request-sample/respiratory-drugs-devices-market ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

2. Respiratory drugs and devices are used to treat respiratory diseases. Major respiratory diseases are asthma, COPD, Bronchitis, and cystic fibrosis. The respiratory drug and device market is anticipated to grow at a CAGR of 7% during the forecast period. As compared to respiratory medical devices, the market of drug is far larger which is driving the overall market. North America is leading the drug market globally. It is due to significant market of patented and branded generic drugs in the region. Around 67%-69% of total market is of respiratory drugs in 2018. Companies such as Astrazeneca, Chiesi Farmaceutici, Merck, Novartis, Roche, Teva, are significantly contributing to the drug market. These companies have more than 50% of the total drug market globally. A full report of Respiratory Drugs https://www.omrglobal.com/industry-reports/respiratory-drugs-devices-market Factors that are augmenting the market include predominance of chronic respiratory diseases such as asthma, COPD and so on, overgrowing geriatric population, changing lifestyle activities among people and innovations and development of new products. Asthma is one of the major non-communicable diseases globally affect almost each major economy. As per WHO, about 235 million people have asthma related diseases globally. It is most common communicable disease in children however maximum mortalities are observed in elderly population. It is highly prevalent in high-income countries however developing economies share a large part of mortalities. To know more information, please request a free report sample https://www.omrglobal.com/request- sample/respiratory-drugs-devices-market Another major factor that is expanding respiratory drug and device market size is overgrowing geriatric population in the major economies of the globe. People of this age group are more prone to respiratory diseases such as Asthma and COPD. As per World Bank, in 2010, geriatric population were 7.6% in 2010 which was equal to 524 million and it has been increased to 8.4% in 2016. It is forecast that it will reach 1.5 billion in 2050 with a share of 16% of total population. More notable point is that, developed and technological advance economies have higher percentage of geriatric population as compare to developing economies & global average. Moreover, as per Centre for Diseases Control and Prevention, about 11.5 million asthma attacks were observed in 2015 including 3 million in children in the US. As per Asthma UK, about 5.4 million people are suffering from asthma in the UK in 2016. Out of 5.4 million people, asthma is prevalent in 4.3 million adults and 1.1 million in children. As per WHO, India is estimated to have about 15-20 million asthma patients in 2017. It is also on high rise in China, as per Asia Asthma Development Board, there were about 36.7 patients of asthma per 100,000 people. There are more than 30 million people living with Asthma in the China. These facts and figures address the demand for respiratory drugs and devices; thereby, expanding the global market size. and Devices Market is available at:

3. Current Market Trends Covered in the Global Respiratory Drugs and Devices Market Report •Based on the type, the respiratory drugs are estimated to hold a dominating market share during the forecast period. •North America is estimated to dominate the global respiratory drugs and devices industry during the forecast period. Global Respiratory Drugs and Devices Market Segmentation By Type •Drugs •Devices Visit here to know more about Global Respiratory Drugs and Devices Market Global Respiratory Drugs and Devices Market – Segment by Region North America •US •Canada Europe •Germany •UK •France •Spain •Italy •Rest of Europe Asia-Pacific •China •India •Japan •Rest of Asia-Pacific

4. Rest of the World •Middle East & Africa •Latin America Company Profiles •AstraZeneca plc •ADAMIS (ADMP) •ADS Biotec •Air Liquide •Alios BioPharma Inc. •ALung Technologies •Alvogen •Anaxsys •Applied BioCode, Inc. •Aptimmune Biologics Inc. •Aptuit LLC •Aradigm •Aros Pharma ApS •Arrow Therapeutics, Ltd. •Avita Medical •Baxter International •Bayer AG •Beximco Pharmaceuticals Ltd. •Biomarck Pharmaceuticals, Ltd. •Bioxydyn Limited •Boehringer Ingelheim About Orion Market Research OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles. For More Information, Visit Orion Market Research

5. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404 Source: Respiratory Drugs and Devices Market